---
layout: post
title: "Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I"
date: 2026-02-05 19:01:49 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-26805
original_published: 2022-12-09 00:00:00 +0000
significance: 8.00
---

# Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** December 09, 2022 00:00 UTC
**Document Number:** 2022-26805

## Summary

With the issuance of this final rule, the Drug Enforcement Administration places N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine), including its salts, isomers, and salts of isomers in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle methiopropamine.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/12/09/2022-26805/schedules-of-controlled-substances-placement-of-methiopropamine-in-schedule-i)
- API: https://www.federalregister.gov/api/v1/documents/2022-26805

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
